Indian Drugmakers Offer Affordable HIV Prevention Drug, Sparking Price and Access Concerns
Indian drugmakers Dr. Reddy’s and Hetero are stepping up to the plate, and the news is pretty remarkable. They’re gearing up to sell a new, highly effective HIV prevention drug, and the price tag is a real game-changer: just $40 a year. That’s an announcement that sparks a lot of thoughts, especially when we consider the often-skyrocketing costs of healthcare in various parts of the world.
The contrast with the US market is stark, to say the least. In America, the branded version of this drug, called Yeztugo, can set you back a staggering $28,000 annually. It’s hard to wrap your head around a situation where a drug that might cost pennies in India ends up costing hundreds of dollars in the US.… Continue reading
Matt Underwood